☰

Alan Mast - Publications

Affiliations: 
University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Pathology, Biochemistry
Tree Info Similar researchers PubMed Report error

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tanratana P, Sachetto ATA, Mast AE, Mackman N. An anti-tissue factor pathway inhibitor antibody increases tissue factor activity in extracellular vesicles isolated from human plasma. Research and Practice in Thrombosis and Haemostasis. 8: 102275. PMID 38187825 DOI: 10.1016/j.rpth.2023.102275  0.398
2022 Maroney SA, Siebert AE, Martinez ND, Rasmussen M, Peterson JA, Weiler H, Lincoln J, Mast AE. Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice. Journal of Thrombosis and Haemostasis : Jth. PMID 36696221 DOI: 10.1016/j.jtha.2022.11.034  0.336
2022 Reitsma SE, Holle LA, Bouck EG, Monroe DM, Mast AE, Burthem J, Bolton-Maggs PHB, Gidley GN, Wolberg AS. Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency. Journal of Thrombosis and Haemostasis : Jth. 21: 467-479. PMID 36696199 DOI: 10.1016/j.jtha.2022.10.005  0.318
2022 Mast AE, Ruf W. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy. Journal of Thrombosis and Haemostasis : Jth. PMID 35279938 DOI: 10.1111/jth.15697  0.393
2021 Peterson JA, Gupta S, Martinez ND, Hardesty B, Maroney SA, Mast AE. Factor V east Texas variant causes bleeding in a three-generation family. Journal of Thrombosis and Haemostasis : Jth. PMID 34847292 DOI: 10.1111/jth.15612  0.349
2020 Maroney SA, Westrick R, Cleuren A, Martinez ND, Siebert AE, Zogg M, Ginsburg D, Weiler H, Mast AE. Tissue factor pathway inhibitor is required for cerebrovascular development in mice. Blood. PMID 32735640 DOI: 10.1182/blood.2020006054  0.31
2019 Ellery PER, Hilden I, Thyregod P, Martinez ND, Maroney SA, Gill JC, Mast AE. Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia. Haemophilia : the Official Journal of the World Federation of Hemophilia. PMID 31608540 DOI: 10.1111/hae.13860  0.419
2019 Castillo MM, Yang Q, Zhan M, Pan AY, Lawlor MW, Mast AE, Sood R. Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency. Blood Advances. 3: 489-498. PMID 30755437 DOI: 10.1182/bloodadvances.2018018853  0.308
2018 Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, Woods RK, Mast AE. Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery. Thrombosis and Haemostasis. PMID 30086574 DOI: 10.1055/S-0038-1667198  0.302
2018 Thomassen S, Mastenbroek TG, Swieringa F, Winckers K, Feijge MAH, Schrijver R, Cosemans JMEM, Maroney SA, Mast AE, Hackeng TM, Heemskerk JWM. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength. Thrombosis and Haemostasis. PMID 29452445 DOI: 10.1055/s-0038-1627453  0.36
2018 Ellery PER, Hilden I, Sejling K, Loftager M, Martinez ND, Maroney SA, Mast AE. Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S. Research and Practice in Thrombosis and Haemostasis. 2: 93-104. PMID 29354797 DOI: 10.1002/rth2.12058  0.439
2018 Wood JP, Song XH, Mast AE. BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum Blood. 132: 1163-1163. DOI: 10.1182/blood-2018-99-118666  0.441
2017 Wood JP, Petersen HH, Yu B, Wu X, Hilden I, Mast AE. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation. Blood Advances. 1: 2692-2702. PMID 29291252 DOI: 10.1182/bloodadvances.2017011098  0.39
2017 Tanratana P, Ellery P, Westmark P, Mast AE, Sheehan JP. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 29097362 DOI: 10.1161/ATVBAHA.117.309919  0.31
2017 Wood JP, Baumann Kreuziger LM, Ellery PER, Maroney SA, Mast AE. Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State. Blood Advances. 1: 386-395. PMID 28580443 DOI: 10.1182/bloodadvances.2016002295  0.442
2016 Wood JP, Baumann Kreuziger LM, Desai UR, Mast AE. Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins. British Journal of Haematology. PMID 27301751 DOI: 10.1111/Bjh.14182  0.438
2016 Peterson JA, Maroney SA, Mast AE. Targeting TFPI for hemophilia treatment. Thrombosis Research. 141: S28-30. PMID 27207418 DOI: 10.1016/S0049-3848(16)30359-0  0.362
2016 Mast AE. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 9-14. PMID 26603155 DOI: 10.1161/ATVBAHA.115.305996  0.37
2016 Peterson JA, Augustsson C, Maroney SA, Heibroch Petersen H, Hilden I, Mast A, Zwifelhofer W. Kunitz 3-Selective but Not Kunitz 2-Selective TFPI Inhibitors Cause Release of Tfpiα from Endothelial Cells: Insights into the Release Mechanism Blood. 128: 2558-2558. DOI: 10.1182/Blood.V128.22.2558.2558  0.378
2015 Wood JP, Baumann Kreuziger L, Camire RM, Mast AE. TFPIα Has Reduced Ability to Inhibit FV Leiden Blood. 126: 423-423. DOI: 10.1182/blood.v126.23.423.423  0.414
2015 Maroney SA, Mast AE. New insights into the biology of tissue factor pathway inhibitor Journal of Thrombosis and Haemostasis. 13: S200-S207. DOI: 10.1111/jth.12897  0.457
2014 Wood JP, Ellery PE, Maroney SA, Mast AE. Biology of tissue factor pathway inhibitor. Blood. 123: 2934-43. PMID 24620349 DOI: 10.1182/blood-2013-11-512764  0.429
2014 Wood JP, Ellery PE, Maroney SA, Mast AE. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 169-76. PMID 24233490 DOI: 10.1161/ATVBAHA.113.302655  0.413
2014 Maroney SA, Ellery PE, Wood JP, Ferrel JP, Martinez ND, Mast AE. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ. Journal of Thrombosis and Haemostasis : Jth. 11: 911-8. PMID 23480518 DOI: 10.1111/jth.12188  0.397
2014 Wood JP, Baumann Kreuziger LM, Camire RM, Desai UR, Mast AE. Relieving Inhibition of Prothrombinase By TFPIα: a Procoagulant Activity of Unfractionated, Low Molecular Weight, and Nonanticoagulant Heparins Blood. 124: 1478-1478. DOI: 10.1182/Blood.V124.21.1478.1478  0.405
2013 Wood JP, Bunce MW, Maroney SA, Tracy PB, Camire RM, Mast AE. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proceedings of the National Academy of Sciences of the United States of America. 110: 17838-43. PMID 24127605 DOI: 10.1073/pnas.1310444110  0.322
2013 Sosa IR, Ellery P, Mast A, Neff AT, Gailani D. Acquired factor V deficiency in a patient without evidence of a classical inhibitor Haemophilia. 20. PMID 24118596 DOI: 10.1111/Hae.12280  0.487
2013 Maroney SA, Hansen KG, Mast AE. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor. Current Opinion in Hematology. 20: 403-9. PMID 23839295 DOI: 10.1097/MOH.0b013e3283634412  0.391
2013 Wood JP, Mast AE. Specific Leucine, Isoleucine and Threonine Residues In The TFPIα C-Terminal Region Are Necessary For Inhibition Of Prothrombinase Blood. 122: 3562-3562. DOI: 10.1182/blood.v122.21.3562.3562  0.36
2012 Maroney SA, Mast AE. Platelet tissue factor pathway inhibitor modulates intravascular coagulation. Thrombosis Research. 129: S21-2. PMID 22425319 DOI: 10.1016/j.thromres.2012.02.023  0.415
2012 Wolberg AS, Mast AE. Tissue factor and factor VIIa--hemostasis and beyond. Thrombosis Research. 129: S1-4. PMID 22417944 DOI: 10.1016/J.Thromres.2012.02.017  0.311
2012 Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor. The Biochemical Journal. 443: 259-66. PMID 22239091 DOI: 10.1042/BJ20111994  0.378
2012 Wood JP, Ellery PER, Maroney SA, Mast AE. Protein S Is a Cofactor for Platelet TFPIα, but Not Cell Surface-Associated TFPI Blood. 120: 494-494. DOI: 10.1182/blood.v120.21.494.494  0.437
2011 Mast AE. Alternatively spliced tissue factor pathway inhibitor: functional implications. Frontiers in Bioscience (Scholar Edition). 3: 1457-62. PMID 21622281  0.399
2011 Gilbert GE, Mast AE. Curbing an inhibitor for hemostasis. Blood. 117: 5277-8. PMID 21596863 DOI: 10.1182/blood-2011-03-342725  0.347
2011 Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Mast AE. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 821-6. PMID 21233452 DOI: 10.1161/Atvbaha.110.220293  0.407
2010 Maroney SA, Ellery PE, Mast AE. Alternatively spliced isoforms of tissue factor pathway inhibitor. Thrombosis Research. 125: S52-6. PMID 20176395 DOI: 10.1016/j.thromres.2010.01.038  0.337
2009 Maroney SA, Ferrel JP, Pan S, White TA, Simari RD, McVey JH, Mast AE. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. Journal of Thrombosis and Haemostasis : Jth. 7: 1106-13. PMID 19422457 DOI: 10.1111/j.1538-7836.2009.03454.x  0.344
2008 Maroney SA, Ferrel JP, Collins ML, Mast AE. Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. Journal of Thrombosis and Haemostasis : Jth. 6: 1344-51. PMID 18503630 DOI: 10.1111/j.1538-7836.2008.03033.x  0.425
2008 Maroney SA, Mast AE. Expression of tissue factor pathway inhibitor by endothelial cells and platelets. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 38: 9-14. PMID 18261960 DOI: 10.1016/j.transci.2007.12.001  0.39
2008 Maroney SA, Ferrel JP, Pan S, White TA, Simari RD, McVey JH, Mast AE. Tissue Specific Expression of Alternatively Spliced Forms of Tissue Factor Pathway Inhibitor (TFPI) in Mice Blood. 112: 1026-1026. DOI: 10.1182/blood.v112.11.1026.1026  0.377
2007 Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, Mast AE. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 109: 1931-7. PMID 17082321 DOI: 10.1182/blood-2006-07-037283  0.337
2006 Chandiwal A, Zaman FS, Mast AE, Hall CL. Factor Xa inhibition by immobilized recombinant tissue factor pathway inhibitor. Journal of Biomaterials Science. Polymer Edition. 17: 1025-37. PMID 17094640 DOI: 10.1163/156856206778366013  0.361
2006 Maroney SA, Cunningham AC, Ferrel J, Hu R, Haberichter S, Mansbach CM, Brodsky RA, Dietzen DJ, Mast AE. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. Journal of Thrombosis and Haemostasis : Jth. 4: 1114-24. PMID 16689766 DOI: 10.1111/J.1538-7836.2006.01873.X  0.612
2006 Donahue BS, Gailani D, Mast AE. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass Journal of Thrombosis and Haemostasis. 4: 1011-1016. PMID 16689752 DOI: 10.1111/J.1538-7836.2006.01896.X  0.42
2005 Maroney SA, Friese P, Alliman S, Dale GL, Mast A. Characterization of Platelet TFPI. Blood. 106: 1937-1937. DOI: 10.1182/blood.v106.11.1937.1937  0.343
2004 Raybagkar DA, Patchipulusu S, Mast AE, Hall CL. In vitro flow evaluation of recombinant tissue factor pathway inhibitor immobilized on collagen impregnated Dacron. Asaio Journal (American Society For Artificial Internal Organs : 1992). 50: 301-5. PMID 15307537 DOI: 10.1097/01.Mat.0000132261.38356.5A  0.359
2003 Dietzen DJ, Jack GG, Page KL, Tetzloff TA, Hall CL, Mast AE. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity. Thrombosis and Haemostasis. 89: 65-73. PMID 12540955 DOI: 10.1267/THRO03010065  0.422
2002 Mast AE, Acharya N, Malecha MJ, Hall CL, Dietzen DJ. Characterization of the association of tissue factor pathway inhibitor with human placenta. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 2099-104. PMID 12482841 DOI: 10.1161/01.Atv.0000042456.84190.F0  0.337
2002 Cunningham AC, Hasty KA, Enghild JJ, Mast AE. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. The Biochemical Journal. 367: 451-8. PMID 12117418 DOI: 10.1042/Bj20020696  0.676
2002 Lockett JM, Mast AE. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor. Biochemistry. 41: 4989-97. PMID 11939795 DOI: 10.1021/bi016058n  0.628
2002 Chandiwal A, Mast AE, Hall CL. Assessment of the efficacy of tissue factor pathway inhibitor (TFPI) immobilized on glass slides to inhibit factor Xa under flow conditions Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 1: 617-618.  0.332
2000 Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ, Hasty KA, Hall CL. Tissue factor pathway inhibitor binds to platelet thrombospondin-1. The Journal of Biological Chemistry. 275: 31715-21. PMID 10922378 DOI: 10.1074/Jbc.M006595200  0.633
1999 Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood. 94: 3922-7. PMID 10572109  0.597
1997 Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL, Broze GJ. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. The Biochemical Journal. 577-83. PMID 9359432 DOI: 10.1042/bj3270577  0.305
1996 Mast AE, Broze GJ. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase Blood. 87: 1845-1850. PMID 8634431  0.435
1995 Warshawsky I, Bu G, Mast A, Saffitz JE, Broze GJ, Schwartz AL. The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo Journal of Clinical Investigation. 95: 1773-1781. PMID 7706485 DOI: 10.1172/Jci117855  0.438
Show low-probability matches.